Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
COSMOS HEALTH INC (COSM)
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-11-04
$0.29-11.51%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.07 → 0.07 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for COSM yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Share buybacks continue to support stock value | A supporting condition in COSMOS HEALTH INC's published investment case. The stated target is Ongoing buyback programs. | Intact | No buybacks announced or buybacks halted | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 13, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative growth business, not a proven compounder, because it is still loss-making and its risk level is high. The long-term thesis is intact, but recent earnings misses and mixed progress on profitability make execution an important test.
The evidence snapshot provides no valuation measure or explicit market expectations, so whether COSM is cheap or expensive versus peers cannot be assessed. Recent earnings misses are known, while the thesis still rests on revenue growth and progress toward profitability.
Near term, revenue growth is substantive, with preliminary nine-month revenue of about $54.3 million, and liabilities have declined sequentially. However, operating losses widened from the first to the second quarter, and three recent earnings misses plus erratic results leave the next report uncertain.
Over the next few quarters, the key test is whether commercial growth can continue while operating losses narrow; another guidance cut would weaken the case. A weakening jobs report could pressure cyclical healthcare names, while continued earnings strength and higher guidance from sector peers could support the sector backdrop.
Over a 1-to-3-year view, COSM has real revenue growth and some balance-sheet progress, but profitability remains unproven and execution risk is high. The thesis hinges on turning growth into improving operating results. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in COSMOS HEALTH INC's published investment case. The stated target is >= $0.07 per share. |
| Intact |
| EPS stays below $0.03 per share in FY 2027 |
Diluted EPS: $-0.10 per share FY2026-Q2; GAAP. Published target: >= $0.07 per share. Annual target cannot be compared with a quarterly or TTM observation. Aug 18, 2026-0.1 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue grows to at least $155.8M by end of 2027 | A primary condition in COSMOS HEALTH INC's published investment case. The stated target is >= $155.8 million. | Intact | revenue falls below $110 million in FY 2027 | Revenue: $18.986M FY2026-Q2; GAAP. Published target: >= $155.8 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 18, 202618,986,376 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.07 → $0.07 · observed estimates
$0.11B → $0.13B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-07-25 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-07-26 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-07-27 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-07-28 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-07-29 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-07-30 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-07-31 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-01 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-02 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-03 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-04 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-05 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-06 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-07 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-08 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-09 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-10 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-11 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-12 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-13 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-14 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-15 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-16 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-17 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-18 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-19 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-20 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-21 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-22 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-23 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-24 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-25 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-26 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-27 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-28 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-29 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-30 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-08-31 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-01 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-02 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-03 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-04 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-05 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-06 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-07 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-08 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-09 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-10 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-11 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-12 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-13 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-14 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-15 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-16 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-17 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-18 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-19 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-20 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-21 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-22 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-23 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-24 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-25 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-26 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-27 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-28 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-29 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-09-30 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-10-01 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-10-02 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-10-03 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-10-04 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-10-05 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-10-06 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-10-07 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-10-08 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-10-09 | $0.07 | $110,800,000 | 1 / 1 |
| 2026-10-10 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-11 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-12 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-13 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-14 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-15 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-16 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-17 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-18 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-19 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-20 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-21 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-22 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-23 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-24 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-25 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-26 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-27 | $0.07 | $128,000,000 | 1 / 1 |
| 2026-10-28 | $0.07 | $129,600,000 | 1 / 1 |
| 2026-10-29 | $0.07 | $129,600,000 | 1 / 1 |
| 2026-10-30 | $0.07 | $129,600,000 | 2 / 2 |
| 2026-10-31 | $0.07 | $129,600,000 | 2 / 2 |
| 2026-11-01 | $0.07 | $129,600,000 | 2 / 2 |
| 2026-11-02 | $0.07 | $129,600,000 | 2 / 2 |
| 2026-11-03 | $0.07 | $129,600,000 | 2 / 2 |
| 2026-11-04 | $0.07 | $129,600,000 | 2 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.